Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT
Clinical trial NCT02201420 · COMPLETED
Trial details
- NCT number
- NCT02201420
- Sponsor
- Navidea Biopharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2015-03-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.